Sponsor:
M.D. Anderson Cancer Center
Code:
NCT00501826
Conditions
T Acute Lymphoblastic Leukemia
T Lymphoblastic Lymphoma
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Cyclophosphamide
Cytarabine
Dexamethasone
Doxorubicin Hydrochloride
Mercaptopurine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2024-12-16.